Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Afro-Egypt. j. infect. enem. dis ; 10(2): 163-173, 2022. tables, figures
Article Dans Anglais | AIM | ID: biblio-1426649

Résumé

In Egypt, the prevalence of hepatitis C virus (HCV) antibodies is the highest worldwide by 7.6%. Applying efficient treatment protocol on large scale could decrease HCV prevalence as well as disease burden.The aim of this study is to compare the efficacy of Sofosbuvir plus ledipasvir versus Sofosbuvir plus daclatasvir in management of chronic hepatitis C Egyptian patients with either easy to treat (naive patients with Child score A5)or difficult to treat (interferon experienced).


Sujets)
Humains , Résultat thérapeutique , Hépatite C chronique , Patients , Études cas-témoins , Sofosbuvir
SÉLECTION CITATIONS
Détails de la recherche